Kairos Pharma, LTD.
KAPA- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001962011
No open-market purchases or sales by Kairos Pharma, LTD. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $371.1K in total; no superinvestor holds it.
Open-market trades, last 90 days
Open-market purchases (P) and sales (S) by Kairos Pharma, LTD. insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.
- Open-market buys
- 0 filings
- Open-market sells
- 0 filings
- Insiders trading
- 0
- Net value
- $0
- Purchases minus sales
Insider roster
Directors, officers and 10% owners who have filed a Form 4 for Kairos Pharma, LTD., current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.
| Name | Title | Last reported holding | Last filing | Filings, past year |
|---|---|---|---|---|
| Bhowmick Neil | Chief Scientific Officer | 1,311,739 | Dec 30, 2025 | 1 |
| Bae Hyun W. | Director | 73,370 | Dec 23, 2025 | 1 |
| Singhvi Rahul | Director | 49,204 | Nov 26, 2025 | 1 |
| Yu John S | CEO and Chairman | 230,105 | Nov 26, 2025 | 1 |
| Keyoung Hansoo Michael | Director | 29,084 | Nov 26, 2025 | 1 |
| Murali Ramachandran | VP of Research and Development | 299,529 | Nov 26, 2025 | 1 |
| Samuelson Doug | Chief Financial Officer | 293,039 | Nov 26, 2025 | 1 |
Insider trades
Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 25, 2024 (view filing) | Nov 25 | Same day | Murali RamachandranVP of Research and Development | PPurchase | +200 | $1.59 | +$318 | +0.2%133.1K after | |
| Nov 25, 2024 (view filing) | Nov 22 | 3 days | Samuelson DougChief Financial Officer | PPurchase | +2.50K | $1.50 | +$3.75K | +4.3%60.8K after | |
| Nov 21, 2024 (view filing) | Nov 20 | 1 day | Yu John SCEO and Chairman | PPurchase | +4.00K | $1.44 | +$5.76K | +0.1%5.34M after |